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Hundreds of millions of people in poor countries continue to suffer from disease caused by
bloodfeeding hookworms. While mice and rats are not reliably permissive hosts for any
human hookworm species, adult Golden Syrian hamsters are fully permissive for the human
and animal pathogen Ancylostoma ceylanicum. Similar to humans, hamsters may be
infected with A. ceylanicum third-stage larvae orally or percutaneously. Oral infection typically leads to consistent worm yields in hamsters but may not accurately reflect the clinical
and immunological manifestations of human infection resulting from skin penetration.

Methodology/Principal findings
In this study we compared host responses following percutaneous infection to those utilizing
an established oral infection protocol. Infected hamsters exhibited a dose-dependent pathology, with 1000 percutaneous larvae (L3) causing anemia and adult worm recovery comparable to that of 50 orally administered L3. A delayed arrival and maturity of worms in the
intestine was observed, as was variation in measured cellular immune responses. A longterm study found that the decline in blood hemoglobin was more gradual and did not reach
levels as low, with the nadir of disease coming later in percutaneously infected hamsters.
Both groups exhibited moderate growth delay, an effect that was more persistent in the percutaneously infected group. Fecal egg output also peaked later and at lower levels in the
percutaneously infected animals. In contrast to orally infected hamsters, antibody titers to
larval antigens continued to increase throughout the course of the experiment in the percutaneous group.

Conclusions/Significance
These results demonstrate that the route of infection with A. ceylanicum impacts disease
pathogenesis, as well as humoral and cellular immune responses in an experimental
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setting. These data further validate the utility of the Golden Syrian hamster as a model of
both oral and percutaneous infection with human hookworms.

Author summary
Hookworms are bloodfeeding intestinal parasites that represent an important cause of
anemia and growth delay in children from Low and Middle Income Countries (LMICs).
The study of hookworm is limited by the limited availability of animal models that accurately reproduce the clinical features of human infection. We report here a detailed
description of hookworm infection in the hamster, with comparison of two routes of
infection: oral vs percutaneous. The results demonstrate differences in the time course of
infection and primary immune responses based on whether infection occurs orally or via
skin penetration. These results build on the current understanding of hookworm pathogenesis and extend the utility of this important animal model of human disease.

Introduction
Despite significant improvements in public health over the past century, hundreds of millions
of persons worldwide continue to suffer from disease caused by hookworms [1–3]. These
bloodfeeding nematodes are a major cause of iron deficiency anemia and rank among the foremost agents of global morbidity [1,2], with a particular burden on children [4]. Although moderately effective anthelminthic agents for hookworm have been available for many years,
reinfection typically occurs quickly following treatment [5–7], and reduced effectiveness has
been documented in human infections [8–12]. In humans, infection with hookworms typically
occurs by one of two potential routes, either through ingestion (Ancylostoma) of infectious
third stage larvae (L3) or via skin penetration (Necator americanus or Ancylostoma) following
contact with soil or vegetation contaminated with L3 [13,14]. Studies in mice utilizing the dog
hookworm A. caninum suggest that hydrolytic enzymes, including proteases and hyaluronidases, facilitate larval skin penetration [15–17] and in vitro assays have demonstrated that antibodies directed at proteins secreted by A. caninum L3 may inhibit this process [17–19].
Following invasion of small cutaneous blood vessels, the worms migrate through the heart and
lungs, where they lodge in the small capillaries. After entering the alveolar space parasites
ascend into the large airways and upon reaching the trachea are swallowed, undergoing two
additional molts to the adult bloodfeeding stage.
While mice and rats are not permissive hosts for the major human-infecting species N.
americanus and A. duodenale, immunocompetent adult Golden Syrian hamsters (HsdHan:
Aura) are fully permissive hosts for A. ceylanicum [20–22], an emerging pathogen of humans
in southeast Asia [23–26]. When orally infected with a sublethal dose of A. ceylanicum L3,
weanling hamsters exhibit the hallmarks of human infection: delayed growth and anemia [27].
Furthermore, we have demonstrated by ELISA and Western immunoblot that outbred hamsters undergoing a primary A. ceylanicum infection acquire vigorous specific serum IgG
responses to soluble adult hookworm somatic extracts and adult excretory-secretory (ES)
products [27–30].
In the experiments described here, the A. ceylanicum hamster model was used to investigate
hookworm pathogenesis and host responses induced by larval skin penetration. Percutaneous
infection of hamsters leads to the establishment of patent infections in infected animals and
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through detailed observations, the time course of parasite development and associated host
pathology, including immune responses are characterized in comparison to animals infected
using the oral infection protocol.

Materials and methods
Ethics statement
All experiments described were reviewed and received prior approval (protocol #10312) from
the Yale University Animal Care and Use Committee. Daily maintenance and care of experimental animals complied with the National Institutes of Health guidelines for the humane use
of laboratory animals and were provided by the Yale Animal Care and Resource Center Staff.

Parasites and hosts
The Ancylostoma ceylanicum life cycle was maintained in male weanling (21 days old) hamsters of the outbred HsdHan:AURA strain (Envigo, Indianapolis, IN) through oral infection
with 150–200 third-stage larvae (L3) freshly isolated from coprocultures [27]. For percutaneous infections, animals were anesthetized, and a small (2 cm square) patch of abdominal skin
shaved with veterinary clippers. Larvae were suspended in a small volume of buffer and
applied to the gauze pad of a Band-Aid Water Block bandage (Johnson & Johnson, New
Brunswick, NJ). The L3-containing bandage was then applied to the exposed skin, secured
with a layer of surgical tape wrapped around the animal’s body and left in place for 24 hours.
Three separate experiments were conducted to evaluate the course of disease and immune
responses in percutaneously infected animals. In Experiment #1, the pathogenesis of percutaneous infection in hamsters (n = 3 per group) was examined in animals infected with various
doses (50, 200, 1000, or 5000 L3). A separate group of animals was orally infected with 50 L3 to
serve as infection controls. Blood hemoglobin levels were measured in all animals for 21 days.
At day 22 post-infection (PI), all hamsters were sacrificed and adult worms in the small intestine were counted. Feces were collected from each animal following sacrifice to determine
individual egg counts.
In the second experiment (Experiment #2), the time course of acute infection in animals
infected percutaneously and orally was compared. Pathology and immune responses were
measured in orally infected animals (n = 9; 100L3) and compared to observations of hamsters
infected through the skin with 2000 L3 (n = 9) as described above. At days 10, 20 and 30 PI, 3
hamsters from each group were euthanized and adult hookworms removed, photographed,
and measured. Spleens and mesenteric lymph nodes were removed, weighed and processed
for FACS analysis as described below [31].
In Experiment #3, long-term disease progression and recovery were characterized by infecting separate groups of animals (n = 6) orally (50 oral L3) or via exposure through the skin
(1000 percutaneous L3). Weight and blood hemoglobin levels were recorded for 100 days PI
and compared to values for control animals that were uninfected. Pooled fecal samples were
collected from infected animals for enumeration of parasite egg output.

Measurement of fecal egg counts
Feces were collected from the large intestines of animals following sacrifice or from live animals temporarily housed on wire grating [32]. Eggs were counted in individual or pooled samples by the method of Gordon and Whitlock [33]. Briefly, fecal samples were mixed and 1 g
suspended in 10 ml saturated NaCl, vortexed for 1 min and filtered through two layers of
gauze. Eggs contained in the top layers of filtrate were counted in each chamber of a McMaster
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slide (Hausser Scientific, Horsham, PA) and viewed using light microscopy. Three separate
preparations were analyzed to determine mean eggs per gram (epg) of feces for each infected
animal or group.

Flow cytometry
Single-cell preparations of spleens and mesenteric lymph nodes were prepared from tissues
recovered from sacrificed animals in experiment 2 [31]. Approximately 106 cells were surface
stained with fluorescein isothiocyanate-labeled goat anti-Syrian hamster immunoglobulin G
(FITC-IgG) and phycoerythrin-labeled anti-mouse CD4 [PE-L3T4; eBiosciences (San Diego,
CA)] previously shown to interact with hamster cells [31,34]. Cell surface determinant data
were acquired for 105 cells per sample, using a FACSCalibur flow cytometer (BD Biosciences,
San Jose, CA). Lymphocytes were selected by forward scatter gating on size, and data were analyzed using the FlowJo software program (Treestar, Ashland, OR).

Parasite antigens
Soluble excretory-secretory products (ES) were obtained from adult hookworms collected
from the intestines of life cycle animals. Orally infected animals were sacrificed 21 days PI and
adult worms removed, rinsed with sterile PBS and incubated at 37˚C in sterile PBS (10 worms
per milliliter) as described [27,35]. Several preparations of frozen ES were thawed, pooled and
filtered (0.45 micron) prior to concentration using a centrifugal concentrator with a 5-kDa
molecular weight cut-off (Millipore Corp., Bedford, MA). Aliquots of concentrated ES were
stored at -80˚C until use.
Soluble hookworm larval extracts (LEX) were prepared from approximately 25,000 A. ceylanicum L3, which were suspended in 50 mM Tris HCl (pH 7.5) before flash freezing in dry ice
ethanol. Incubation at 37˚C for 5 minutes following freezing was performed twice. Insoluble
material was pelleted by centrifugation (15,000x g) for 15 minutes at 4˚C. The soluble supernatants were combined and aliquots stored frozen -80˚C until use.
Recombinant Ancylostoma ceylanicum excretory-secretory protein 2 (rAceES-2) expression
was induced in transformed E.coli (BL21 [DE3] strain) and soluble protein purified from cell
pellets using sonication and chelation chromatography [28]. Elution fractions containing
recombinant protein were dialyzed into PBS prior to -80˚C storage.

Enzyme-linked immunosorbent assays (ELISAs)
Serum samples were obtained from animals throughout the course of the Experiment #3 for
the evaluation of systemic parasite-specific antibodies. Previously frozen adult worm ES was
diluted to 2 μg/ml in sterile PBS and 100 microliters were added to individual wells of a 96 well
Immulon-2HB microtiter plate (Dynex, Chantilly, VA) overnight at 4˚C. The plates were
washed 4 × with PBS-T (PBS and 0.05% Tween-20) and blocked for 1h at RT with 1% milk in
PBS. Blocked plates were washed and then incubated for 3h at RT with serum serially diluted
in 1% milk/PBS-T to a final volume of 100 μL/well. Plates were washed 6 × and incubated for
2h at RT with HRP-conjugated goat anti-hamster IgG (1:1000) in 1% milk/PBS-T. Bound
HRP was visualized in washed plates by the addition of 100 μ L/well substrate solution (1 mg/
mL ABTS [2,20 -azinobis (3-thylbenzthiazoline- 6-sulphonic acid); Sigma] in 0�1 M citrate
buffer, pH 5�0, 0�03% H2O2). After 30 minutes incubation, the Abs405 was recorded using a
SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA). All values were normalized to a positive standard which was included in each assay to control for day-to-day
variation.
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Statistics
Numerical data is presented in the figures as means of individual or pooled samples as
indicated ± SD. Statistical analysis was performed using the GraphPad Prism v6 software package (GraphPad Software, San Diego, CA) with specific tests indicated in the figure legends. In
all cases P-values of < 0.05 were considered significant.

Results
Experiment #1: dose response
We first conducted an experiment in which weanling hamsters were percutaneously infected
with a range of larval doses, with orally infected and uninfected hamsters serving as controls.
Percutaneous infection of weanling hamsters resulted in a dose-dependent acute skin reaction
visible by 2 days after exposure to larvae (Fig 1). As the infection proceeded, hamsters percutaneously infected with the lowest doses, 50 and 200 L3, displayed no overt pathology, having
blood hemoglobin levels statistically equivalent to those of uninfected control animals (Fig
2A). This contrasted with hamsters receiving higher percutaneous doses (1000 or 5000 L3),
which exhibited reductions in hemoglobin levels compared to uninfected controls (Fig 2A).
Animals percutaneously infected with 1000 L3 displayed moderate reductions in hemoglobin
(2.5 g/dl decrease in mean levels by day 21 post infection as compared to day 9 levels, representing a 17.9% decline), similar to those receiving 50 L3 orally (2.1 g/dL decrease, or -14.6%).
Severe pathology, however, was observed in animals receiving 5000 L3 percutaneously, with
steep declines in hemoglobin compared to the uninfected control group and all other infected
groups (Fig 2A). Blood hemoglobin levels in the 5000 percutaneously infected hamster ultimately reached the lowest levels measured in any group (6.1 g/dL drop from day 9 to 21, a
43.3% decrease).

Fig 1. Representative photographs of hamsters following percutaneous infection, Experiment 1. Left panel shows the application of larvae to the abdominal
area using an adhesive bandage as described in the Materials and Methods. Remaining panels show animals two days after infection with the indicated number
of hookworm larvae. Dotted lines indicate extent of skin reaction to larval penetration.
https://doi.org/10.1371/journal.pntd.0010098.g001
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Fig 2. Pathology, worm burden and fecal egg output following percutaneous infection (Experiment 1). Hamsters
(n = 3 each group) were infected with the indicated number of A. ceylanicum L3 by oral or percutaneous (PERC)
route. Mean blood hemoglobin levels +/- Standard Deviation (SD) are presented in [A], intestinal worm burdens at
day 22 PI are shown in [B] as absolute numbers (left) or yield expressed as percent of inoculum (right), and mean fecal
egg output in [C] as calculated per gram of feces (EPG) recovered from the large intestines of individual animals (left)
or EPG per recovered worm (right). Symbols in [A] indicate level of statistical significance by Fisher’s Least Significant
Difference post-test following a two-way ANOVA: for the comparison to uninfected (0 L3) animals � indicates P<
0.05. For the comparison of 1000 L3 percutaneous and 5000 L3 percutaneous groups, 4 indicates P< 0.05. In [B] and
[C] brackets indicate statistically significant comparisons by one-way ANOVA, with P values given above the brackets.
https://doi.org/10.1371/journal.pntd.0010098.g002

At the time of sacrifice, the mean +/- SD adult intestinal worm burden (Fig 2B, left) at 22
days PI was 19.0 +/- 10.1 in the 50 oral L3 group, representing a 38.0% yield of the initial inoculum (Fig 2B, right) and consistent with previous findings [27,28,35,36]. By comparison, the
mean worm burden in the 1000 L3 percutaneously infected group (32.3 +/- 21.7) was statistically equivalent to that of the 50 L3 oral animals, but the yield (3.2%) was more than 10X
lower. The mean worm burden (97.3 +/- 33.3) in the 5000 L3 percutaneously infected group
was considerably higher than either the 50 oral L3 or 1000 L3 percutaneous groups, although
the overall yield of adult worms (1.9%) was equivalent that of the 1000 L3 percutaneous group.
Consistent with the lack of observable pathology in the lowest dose percutaneous groups, no
worms were recovered from any of the 50 L3 animals and only one of the 200 L3 animals was
found to be infected, harboring two worms.
Consistent with the pathology and worm burden data, measurement of fecal eggs in individual animals demonstrated that the 50 oral L3 and 1000 percutaneous L3 groups had equivalent absolute counts (3855 +/- 2108 vs. 3717 +/- 2261 epg; Fig 2C left). Likewise, the highest
egg counts were measured in the 5000 percutaneous L3 group (6500 +/- 2763 epg), although
the difference was not statistically significant when compared to other groups. However, calculation of epg per recovered worm (Fig 2C right) revealed a higher ratio in the 50 oral L3 group
(200 +/- 51) compared to the 1000 and 5000 percutaneous L3 groups (117 +/- 29 and 68 +/19, respectively). No eggs were observed in any fecal sample from 50 and 200 percutaneous L3
groups.

Experiment 2: time course of primary infection
In the second set of experiments, parasite development and host responses were compared in
animals infected orally with 100 L3 or 2000 L3 administered on the gauze bandage as described
above. Animals were sacrificed on days 10, 20 and 30 post infection and the number of adult
worms were counted and worm lengths measured. The spleens and mesenteric lymph nodes
(MLN) from all animals were weighed and cellular profiles acquired. Adult worm yields were
significantly higher on days 10 and 20 PI in the orally infected animals (p = 0.0003 and
p = 0.0015; Fig 3A), with values declining at each time point. The lowest values were observed
at 30 days PI. In contrast, the worm burdens in the animals percutaneously infected with 2000
L3 increased over the course of the experiment with highest values seen 30 days PI (Fig 3A).
The rise over time in the number of adult worms recovered from the small intestines in
skin infected animals is likely due to larval migration and development within host tissues and
the corresponding staggered maturity to bloodfeeding adults. This hypothesis is supported by
the worm length data (Fig 3B and 3C) that shows while worms collected from the intestines of
these animals were smaller at 20 and 30 days PI (Fig 3B), worm lengths continued to increase
over the course of the experiment.
Spleens and MLNs from necropsied animals were recovered, weighed and lymphocytes prepared for analysis for surface IgG and CD4 expression. By 20 days PI, spleen weights from the
orally infected hamsters had increased more than threefold over the day 10 PI values, and were
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Fig 3. Intestinal worm burden and worm lengths following percutaneous infection (Experiment 2). Hamsters (n = 9 each group)
were infected with 100 L3 by the oral route or 2000 L3 by the percutaneous (PERC) route. At days indicated, three animals from each
group were sacrificed and intestinal worms recovered, counted and measured. Mean +/- SD intestinal worm burdens at each time
point are shown in [A], worm length at each time point in [B] and representative photographs of worms recovered at each time point
in [C]. In [A] and [B] brackets indicate statistically significant comparisons by Welch t test, with P values given above the brackets.
https://doi.org/10.1371/journal.pntd.0010098.g003

more than double that of percutaneously infected animals (p = 0.001; Fig 4A). By 30 days PI,
however, spleen weights in the percutaneously infected animals had more than doubled to
become statistically equivalent to the orally infected animals. The mean weights of MLNs of
both groups increased over the duration of the experiment, with a significant difference seen
only at day 10 when the MLNs from orally infected animals were larger (p = 0.015; Fig 4E).
Cellular immune responses in the spleen and MLNs were measured at 10 and 20 days PI.
The day 30 PI data could not be obtained due to a technical issue leading to loss of samples
prior to FACS analysis. The percentage of lymphoblasts in the spleen (Fig 4B) was equivalent
between the two infection groups at 10 days PI, but decreased to a significantly lower level in
the orally infected group at 20 days PI (p = 0.003). Conversely, the percentage of blasts in the
MLNs (Fig 4F) was greater in orally infected hamsters (p = 0.002) at 10 days PI, but in both
groups had increased to equivalent levels by day 20 PI. The mean percentage of CD4+ lymphocytes in the spleen (Fig 4C) decreased almost fivefold in orally infected hamsters from 10 to 20
days PI and was lower than that of the percutaneously infected animals at 20 days PI; in the
MLN the mean CD4+ percentage remained relatively stable and equivalent between the two
groups (Fig 4G). The mean percentage of surface IgG+ lymphocytes in the spleen (Fig 4D)
decreased by almost half in orally infected hamsters from 10 to 20 days PI and was lower than
that of the percutaneously infected animals at day 20 PI (p = 0.009). Of note, the mean percentage of IgG+ lymphocytes in the MLNs of percutaneously infected hamsters (Fig 4H) was twofold higher than orally infected animals at day 10 PI (p = .025), but by 20 days PI the mean IgG
+ percentage of both groups had declined almost tenfold and were statistically equivalent.
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Fig 4. Organ weight and cellular data following percutaneous infection (Experiment 2). Hamsters (n = 9 each group) were infected with 100 L3 by the oral
route or 2000 L3 by the percutaneous route. At days indicated, 3 animals from each group were sacrificed and organs recovered, weighed, and lymphocytes
analyzed by flow cytometry. For the spleen, mean organ weights are shown in [A], percentage of blasting lymphocytes in [B], percentage of CD4-positive
lymphocytes in [C] and percentage of IgG-positive lymphocytes in [D]; the corresponding data for mesenteric lymph nodes is shown in [E-H]. In all panels
brackets indicate statistically significant comparisons by Welch t test, with P values given above the brackets. Bars represent Mean values +/- SD.
https://doi.org/10.1371/journal.pntd.0010098.g004

Experiment 3: long term disease progression and recovery
A long-term infection of hamsters comparing sublethal oral and percutaneous infections was
used to evaluate progression of disease parameters (weight and blood hemoglobin) and fecal
egg excretion, as well as the development of systemic antibody responses to parasite antigens.
Animals receiving oral doses of infectious larvae exhibited a characteristic rapid decline in
blood hemoglobin (Fig 5A) and growth delay (Fig 5B), reaching a nadir approximately 3
weeks PI, which also coincided with peak fecal egg excretion in this group (Fig 5C). Orally
infected hamsters then showed signs of recovery as evidenced by improvements in both disease parameters and coincident decline of fecal egg output. Hemoglobin levels of percutaneously infected animals also declined, however compared to orally infected hamsters the decline
was more gradual, less pronounced, and the nadir of disease (28 days PI) occurred later (Fig
5A). Like orally infected animals, percutaneously infected animals exhibited moderate growth
delay, although this effect was more persistent in the percutaneously infected group (Fig 5B).
Fecal egg output peaked later in the percutaneously infected animals and never exceeded 1000
epg; by contrast the levels in orally infected animals peaked above 3000 epg by day 23 PI
(Fig 5C).
The onset and progression of systemic antibody titers to worm antigens from different life
stages varied between exposure groups, with higher titers to larval antigens seen in percutaneously infected animals (Fig 6A). In those animals, titers to larval antigens continued to increase
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Fig 5. Pathology and fecal egg output following percutaneous infection (Experiment 3). Hamsters (n = 6 each
group) were infected with the indicated number of L3 by oral or percutaneous route. Mean blood hemoglobin levels
over time are presented in [A], weight change over time in [B] and pooled fecal egg output in [C]. Data points
represent Mean +/- SD. Symbols in [A] and [B] indicate level of statistical significance by Fisher’s Least Significant
Difference post-test following a two-way ANOVA: for the comparison to 0 L3 � indicates P< 0.05. For the comparison
of 50 L3 oral and 1000 L3 percutaneous groups, 4 indicates P< 0.05.
https://doi.org/10.1371/journal.pntd.0010098.g005

throughout the course of the experiment. In contrast, higher titers to adult ES antigens were
present throughout the experiment in orally infected animals (Fig 6B). Antibody responses to
the highly immunogenic ES antigen AceES-2 exhibited similar kinetics in both groups of
infected animals (Fig 6C), suggesting that route of infection has little effect on the development
of systemic IgG to this ES antigen.

Discussion
Among the challenges facing parasitologists is access to reproducible animal models that accurately reflect the major clinical features of human disease. The study of hookworm highlights
this difficulty, as the two most common human parasite species (Necator americanus and
Ancylostoma duodenale) do not reliably complete their life cycle in laboratory mice or rats.
There are reports in the literature describing the use of rabbit kits [37], puppies [38], neonate
hamsters [39], and/or the use of immunosuppressive agents [40] for the characterization of
infections with human hookworms. While such studies have advanced the field of parasitology, pathological and immune response data collected from these systems may be challenging
to generalize to human infection and disease.
Although primarily a zoonotic pathogen of cats and dogs, Ancylostoma ceylanicum is the
second most common hookworm infecting people in Southeast Asia [26,41,42]. Studies using
the hamster model suggest that oral infections with Ancylostoma ceylanicum [26,41] closely
approximate some observations made in human infections [27,31,32,43], which has added to
our understanding of hookworm pathogenesis and the host-parasite interaction. Establishment of patent A. ceylanicum infections in outbred Golden Syrian hamsters has made possible
detailed characterizations of hookworm disease pathogenesis [27], evaluation of therapeutic
interventions [36,44–47], vaccine development [27,48–54], and characterization of innate/
acquired immune responses [31,34,35,45].

Fig 6. Hookworm-specific antibody responses following percutaneous infection (Experiment 3). Hamsters (n = 6 each group) were infected
with the indicated number of L3 by oral or percutaneous route. Specific IgG titers against soluble larval extract (LEX) in pooled hamster sera are
presented in [A], titers against adult worm excretory-secretory (ES) antigens are presented in [B], and rAceES-2-specific titers in [C]. Data
points represent Mean +/- SD.
https://doi.org/10.1371/journal.pntd.0010098.g006
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Studies in the hamster model of A. ceylanicum that have utilized the oral infection route
confirm that it is highly reproducible and has a relatively short pre-patent period (approximately 20 days) [27,55]. However, since A. ceylanicum larvae administered by oral gavage do
not undergo the tissue migration that follows percutaneous infection [56], the model has
important limitations for understanding certain aspects of pathogenesis, in particular systemic
responses to larval invasion. The results presented here provide a more detailed analysis of the
time course, inoculum-dependent pathology, and the immune response to primary percutaneous infection of Golden Syrian hamsters with A. ceylanicum. In the current set of experiments,
we demonstrate dose-dependent pathology and worm burdens in percutaneously infected
hamsters (Fig 2). As seen in experimental human infections [57,58], low intensity infections
did not result in anemia or significant growth delay. Following percutaneous exposure to
higher doses of hookworm larvae, we observed an expected onset of disease (anemia) correlating with the arrival and maturity of adult worms in the intestine (Fig 3) following larval tissue
migration. From the parasitology perspective, these data demonstrate that the oral route is substantially more efficient than the percutaneous route, with higher yields and intensity of infection following oral dosing at 50 L3 comparable to an inoculum of 1000 L3 administered via the
skin. One possible explanation for the difference is that tissue migration requires the parasite
to evade multiple host defenses, including the skin and respiratory systems, both of which contain potent innate immune effectors. By contrast, when administered by oral gavage, the L3
undergo successive molts to the adult stage exclusively in the gastrointestinal tract [56], which
may present fewer obstacles to further parasite development and survival of the adult worms.
Although it’s possible that long term (>20 years) passage of this laboratory adapted strain of
A. ceylanicum via oral infection of hamsters has resulted in a loss of infectious capacity via percutaneous exposure, our results are comparable to findings of Garside and Behnke [56], who
also demonstrated substantially reduced yield of adult worms following percutaneous infection
compared to oral gavage.
The staggered worm maturity and associated pathology observed following percutaneous
infection were associated with impaired cellular immune responses (Fig 4), similar to prior
investigations in the oral infection model [30,31,50]. Those studies demonstrated that oral
infection with A. ceylanicum blunts the cellular and humoral immune responses as observed in
experimental human infections with N. americanus [59,60]. In humans, reinfection with hookworms also leads to reduced cellular immune responses and faster parasite establishment compared to primary infections [57]. This may account for the continued accrual of adult worms
and the establishment of chronic infections in humans living in endemic areas. Interestingly,
however, the immune cell profiles differed between oral and percutaneous infection models.
For example, although the spleens of orally infected animals were significantly larger than
those from percutaneously infected hamsters, the latter group exhibited much higher percentages of spleen lymphoblasts, CD4+ T cells and surface IgG+ B cells. For comparison, previous
studies have demonstrated that oral infection with A. ceylanicum is associated with a reduction
in CD4+ splenocytes and CD4+ MLNs, as well as reduced numbers of IgG+ B cells in the
spleen, compared to uninfected controls at day 20 post-infection [31]. The results reported
here are perhaps explained by the observation that oral infection is associated with a more synchronous and earlier exposure to adult worm antigens in the gut, while percutaneous infection
is associated with a gradual accumulation of adult worms that takes place over a more protracted period of time. In addition, the data suggest that the predominant mechanism of hookworm associated immune suppression, at least in this model, most likely involves adult worms
in the intestine rather than tissue migrating L3. The delayed and asynchronous establishment
of adult worms in the intestine can also be surmised from the data in Fig 5, which shows distinct patterns of anemia, growth delay and fecal egg excretion between the two routes of
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infection. The two profiles are consistent with an earlier and more intense peak of adult worm
bloodfeeding and egg excretion in the orally infected animals, similar to prior results in this
model. By contrast, the drop in blood hemoglobin in the percutaneously infected animals is
less pronounced, as is the pattern of fecal egg excretion. Of note, however, percutaneous infection appears to be associated with a more sustained period of growth delay compared to the
oral infection route.
Not unexpectedly, higher anti-larval stage antibody titers were noted in percutaneously
infected animals compared to those animals infected orally (Fig 6). These higher titers likely
resulted from increased antigen exposure and accompanying processing by immune effector
cells following the attrition and degradation of larvae in the course of tissue migration. Of
note, however, antibody titers to L3 protein extracts continued to rise across the 100 day experiment. This result suggests that there is an ongoing source of immune stimulation, perhaps
due to a reservoir of degraded or tissue arrested L3. Observations of infected animals exposed
to trickle oral infections reveal similar patterns of higher larval antibody titers corresponding
to continued susceptibility to infection [61]. Also of note is the late decline in IgG antibodies
directed at adult worm ES in the percutaneous infection group, a result that could be explained
by reduced numbers of adult worms compared to the oral infection group. Despite these differences, we observed nearly identical IgG responses in both groups to A. ceylanicum ES-protein 2 (AceES-2) a highly antigenic, netrin-like protein secreted by adult hookworms in the
hamster host [28,62,63]. This result suggests that AceES-2 is a persistent stimulus for antibody
production in the hamster, regardless of the route of exposure. How this novel parasite secretory protein mediates pathogenesis and/or acquired immunity to hookworm in vivo remains
to be determined.
We propose that infection of hamsters with hookworm larvae by the percutaneous route
provides an alternative and biologically relevant experimental model of human hookworm disease, one that provides insight into features of infection resulting from this route of exposure.
Unlike the hookworm Necator americanus, A. duodenale and A. ceylanicum are also infectious
orally, although it is challenging to define the ratio of oral vs percutaneous infections occurring
in human populations. Further characterizing both routes of infection and defining host
responses that are unique to each should lead to a better understanding of hookworm immunoepidemiology and transmission dynamics in endemic populations. The continued characterization of the Syrian hamster model to include studies such as these, coupled with the
expanded availability of reagents and methods for this rodent host species [64,65] will also provide a useful foundation for future work focused on developing effective therapeutic drugs,
preventive vaccines and diagnostics.

Supporting information
S1 Data. Primary data from Experiment 1 (sheets 1–5), Experiment 2 (sheets 6–15), and
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